Filtros de búsqueda

Lista de obras de Elisabeth Ralfkiaer

15-year follow-up of the Second Nordic Mantle Cell Lymphoma trial (MCL2): prolonged remissions without survival plateau

artículo científico publicado en 2016

A novel xenograft model of cutaneous T-cell lymphoma

artículo científico publicado en 2010

ATM mutations are associated with inactivation of the ARF-TP53 tumor suppressor pathway in diffuse large B-cell lymphoma

artículo científico publicado en 2002

Conjunctival Lymphoma--An International Multicenter Retrospective Study

artículo científico publicado en 2016

Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL)

artículo científico publicado en 2011

Diffuse large B-cell lymphoma with combined TP53 mutation and MIR34A methylation: Another "double hit" lymphoma with very poor outcome?

artículo científico publicado en 2014

Ectopic expression of B-lymphoid kinase in cutaneous T-cell lymphoma

artículo científico publicado en 2009

Expression of miR-155 and miR-126 in situ in cutaneous T-cell lymphoma.

artículo científico publicado en 2013

FOXP3 positive regulatory T-cells in cutaneous and systemic CD30 positive T-cell lymphoproliferations

artículo científico publicado en 2008

Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma

artículo científico publicado en 2016

Genetic and epigenetic alterations of the reduced folate carrier in untreated diffuse large B-cell lymphoma

artículo científico publicado en 2007

Genome-wide profiling identifies a DNA methylation signature that associates with TET2 mutations in diffuse large B-cell lymphoma

scientific article published on 05 July 2013

Global hypomethylation is an independent prognostic factor in diffuse large B cell lymphoma

artículo científico publicado en 2017

Histone deacetylase 1, 2, 6 and acetylated histone H4 in B- and T-cell lymphomas

artículo científico publicado en 2009

Hypermethylation of DAPK1 is an independent prognostic factor predicting survival in diffuse large B-cell lymphoma

artículo científico publicado en 2014

Investigation of MGMT and DAPK1 methylation patterns in diffuse large B-cell lymphoma using allelic MSP-pyrosequencing

scientific article published on 27 September 2013

Ki-67 as a prognostic marker in mantle cell lymphoma-consensus guidelines of the pathology panel of the European MCL Network

artículo científico publicado en 2009

Lenalidomide-bendamustine-rituximab in patients older than 65 years with untreated mantle cell lymphoma.

artículo científico publicado en 2016

Lipocalin 2 is protective against E. coli pneumonia

artículo científico publicado en 2010

Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group

artículo científico publicado en 2008

Loss of PRDM11 promotes MYC-driven lymphomagenesis

scientific journal article

Lymphoma of the Eyelid - An International Multicenter Retrospective Study

artículo científico publicado en 2017

Malignant T cells express lymphotoxin α and drive endothelial activation in cutaneous T cell lymphoma

artículo científico publicado en 2015

Malignant cutaneous T-cell lymphoma cells express IL-17 utilizing the Jak3/Stat3 signaling pathway

artículo científico publicado en 2011

Microarray-based classification of diffuse large B-cell lymphoma

artículo científico publicado en 2005

Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 Years.

artículo científico publicado en 2016

Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem-cell support: still very long survival but late relapses do occur

artículo científico publicado en 2012

Nordic MCL3 study: 90Y-ibritumomab-tiuxetan added to BEAM/C in non-CR patients before transplant in mantle cell lymphoma

artículo científico publicado en 2014

Notch1 as a potential therapeutic target in cutaneous T-cell lymphoma

artículo científico publicado en 2010

Onco-miR-155 targets SHIP1 to promote TNFalpha-dependent growth of B cell lymphomas

artículo científico publicado en 2009

SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma--a Nordic Lymphoma Group study

artículo científico publicado en 2014

STAT3 activation and infiltration of eosinophil granulocytes in mycosis fungoides.

artículo científico publicado en 2014

STAT5 induces miR-21 expression in cutaneous T cell lymphoma.

artículo científico publicado en 2016

STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma

artículo científico publicado en 2013

TP53 Gene Status Affects Survival in Advanced Mycosis Fungoides

artículo científico publicado en 2016

TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy

artículo científico publicado en 2016

The Mantle Cell Lymphoma International Prognostic Index (MIPI) is superior to the International Prognostic Index (IPI) in predicting survival following intensive first-line immunochemotherapy and autologous stem cell transplantation (ASCT).

artículo científico publicado en 2009

Validation of a diagnostic microRNA classifier in cutaneous T-cell lymphomas

artículo científico publicado en 2013

WHO classification 2008 of myeloproliferative neoplasms: a workshop learning effect--the Danish experience

artículo científico publicado en 2015

WHO-EORTC classification for cutaneous lymphomas

artículo científico publicado en 2005

WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects

artículo científico publicado en 2005